Literature DB >> 33022061

In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs-a systematic review and meta-analysis.

Emma L M Jennings1,2, Kevin D Murphy3, Paul Gallagher1,2, Denis O'Mahony1,2.   

Abstract

BACKGROUND: the prevalence of adverse drug reactions (ADRs) in hospitalised older patients, their clinical presentations, causative drugs, severity, preventability and measurable outcomes are unclear, ADRs being an increasing challenge to older patient safety.
METHODS: we systematically searched PubMed, Embase, EBSCO-CINAHL, the Cochrane Library, 'rey' literature and relevant systematic review bibliographies, published from database inception to March 2020. We included any study reporting occurrence of in-hospital ADRs as primary or secondary outcomes in hospitalised older adults (mean age ≥ 65 years). Two authors independently extracted relevant information and appraised studies for bias. Study characteristics, ADR clinical presentations, causative drugs, severity, preventability and clinical outcomes were analysed. Study estimates were pooled using random-effects meta-analytic models.
RESULTS: from 2,399 abstracts, we undertook full-text screening in 286, identifying 27 studies (29 papers). Final analysis yielded a pooled ADR prevalence of 16% (95%CI 12-22%, I2 98%,τ2 0.8585), in a population of 20,153 hospitalised patients aged ≥65 years of whom 2,479 patients experienced ≥ one ADR. ADR ascertainment was highly heterogeneous. Almost 48.3% of all ADRs involved five presentations: fluid/electrolyte disturbances (17.3%), gastrointestinal motility/defaecation disorders (13.3%), renal disorders (8.2%), hypotension/blood pressure dysregulation disorders/shock (5.5%) and delirium (4.1%). Four drug classes accounted for 57.8% of causative medications i.e. diuretics (19.8%), anti-bacterials (14.8%), antithrombotic agents (12.2%) and analgesics (10.9%). Pooled analysis of severity was not feasible. Four studies reported the majority of ADRs as preventable (55-95%).
CONCLUSIONS: on average, 16% of hospitalised older patients experience significant ADRs, varying in severity and mostly preventable, with commonly prescribed drug classes accounting for most ADRs.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adverse drug reaction; iatrogenic; inpatient; multi-morbidity; older people; polypharmacy

Mesh:

Substances:

Year:  2020        PMID: 33022061     DOI: 10.1093/ageing/afaa188

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   12.782


  12 in total

Review 1.  Polypharmacy in elderly people.

Authors:  Peter Dovjak
Journal:  Wien Med Wochenschr       Date:  2022-01-10

2.  Hospitalizations of older people in an emergency department related to potential medication-induced hyperactive delirium: a cross-sectional study.

Authors:  Júlia Raso; Lincoln Marques Cavalcante Santos; Débora Alves Reis; Marília Amaral Costa Frangiotti; Ariane Cristina Barboza Zanetti; Helaine Carneiro Capucho; Maria Teresa Herdeiro; Fátima Roque; Leonardo Régis Leira Pereira; Fabiana Rossi Varallo
Journal:  Int J Clin Pharm       Date:  2022-01-27

Review 3.  Preoperative Deprescribing for Medical Optimization of Older Adults Undergoing Surgery: A Systematic Review.

Authors:  Ji Won Lee; Mengchi Li; Cynthia M Boyd; Ariel R Green; Sarah L Szanton
Journal:  J Am Med Dir Assoc       Date:  2021-11-30       Impact factor: 4.669

Review 4.  Frailty in older adults with heart disease.

Authors:  Peter Dovjak
Journal:  Z Gerontol Geriatr       Date:  2022-06-20       Impact factor: 1.292

5.  The effect of clinical pharmacists' intervention in adverse drug reaction reporting: a retrospective analysis with a 9-year interrupted time series.

Authors:  Tianwei Lan; Hua Wang; Xin Li; Hang Yin; Dan Shao; Yueyao Jiang; Qian Yu
Journal:  BMC Health Serv Res       Date:  2022-07-19       Impact factor: 2.908

Review 6.  Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis.

Authors:  Tadele Mekuriya Yadesa; Freddy Eric Kitutu; Serawit Deyno; Patrick Engeu Ogwang; Robert Tamukong; Paul E Alele
Journal:  SAGE Open Med       Date:  2021-08-18

7.  Prevalence, Incidence, and Characteristics of Adverse Drug Reactions Among Older Adults Hospitalized at Mbarara Regional Referral Hospital, Uganda: A Prospective Cohort Study.

Authors:  Tadele Mekuriya Yadesa; Freddy Eric Kitutu; Robert Tamukong; Paul E Alele
Journal:  Clin Interv Aging       Date:  2021-09-22       Impact factor: 4.458

8.  Implementation of Pharmacogenomics and Artificial Intelligence Tools for Chronic Disease Management in Primary Care Setting.

Authors:  Patrick Silva; David Jacobs; John Kriak; Asim Abu-Baker; George Udeani; Gabriel Neal; Kenneth Ramos
Journal:  J Pers Med       Date:  2021-05-21

9.  Design, development, and deployment of an indication- and kidney function-based decision support tool to optimize treatment and reduce medication dosing errors.

Authors:  Jamie S Hirsch; Rajdeep Brar; Christopher Forrer; Christine Sung; Richard Roycroft; Pradeep Seelamneni; Hemala Dabir; Ambareen Naseer; Pranisha Gautam-Goyal; Kevin R Bock; Michael I Oppenheim
Journal:  JAMIA Open       Date:  2021-06-30

10.  Association between statin use and physical performance in home-dwelling older patients receiving polypharmacy: cross-sectional study.

Authors:  Sigbjørn Veddeng; Håkon Madland; Espen Molden; Torgeir Bruun Wyller; Rita Romskaug
Journal:  BMC Geriatr       Date:  2022-03-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.